Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Funding, disease area, and internal validity of hepatobiliary randomized clinical trials

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk Factors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Who is wrong? Responses to Kwo et al

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  1. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sertraline in primary care: comments on the PANDA trial

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer
The aim of this study was to assess whether funding and the disease area are related to the internal validity of hepatobiliary randomized clinical trials.
OriginalsprogEngelsk
TidsskriftAmerican Journal of Gastroenterology
Vol/bind97
Udgave nummer11
Sider (fra-til)2708-13
Antal sider6
ISSN0002-9270
DOI
StatusUdgivet - nov. 2002

ID: 38927765